Back to search
FDAFDA · Food and drugs·Recall number D-1179-2017

Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wrap packs (NDC 0781-3407-95), Rx only, Manufactured in Austria by Sandoz GmbH or Sandoz Inc., Princeton, NJ 08540.

Published October 4, 2017 · Recall initiated: September 25, 2017

Summary

FDA records drug Class III recall D-1179-2017, published October 4, 2017 and initiated September 25, 2017. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 13,435 shrink wrap packs; Lot: Lot: GH8254, Exp 06/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

What to do

Voluntary: Firm initiated · Letter

Get an email if AMPICILLIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMPICILLIN
Manufacturer
Sandoz Inc
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot: GH8254, Exp 06/19
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wrap packs (NDC 0781-3407-95), Rx only, Manufactured in Austria by Sandoz GmbH or Sandoz Inc., Princeton, NJ 08540. recalled?

Yes. FDA published recall D-1179-2017 on October 4, 2017. Reported hazard: Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMPICILLIN.